Infinity Group Invests 120 Million RMB in Shijiazhuang Xingbai Pharmaceutical Company Limited, China
Published: Mar 01, 2011
SHIJIAZHUANG (SJZ), China & TEL AVIV, Israel--(BUSINESS WIRE)--Infinity Group, an RMB fund pioneer and the leader in cross border China RMB and dollar private equity funds, announced today that it is investing 120 million RMB ($US18 million) in Shijiazhuang Xingbai Pharmaceutical Company Limited. Four of Infinity’s funds - the SJZ fund, the I-China fund, the Changzhou fund and the Tianjin fund - participated in this investment. The financing is earmarked to enhance Shijiazhuang Xingbai’s bio-tech capabilities with the goal of better competing on domestic and international markets. Shijiazhuang Xingbai is planning an IPO in the A-share market in three years.